Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 29, 2025 03:57 ET | Source: Mordor Intelligence

USD 9.6 Bn Telecom Expense Management Market Opportunities Analyzed in a 2025-2030 Research Report by Mordor Intelligence

Hyderabad, India, Dec. 29, 2025 (GLOBE NEWSWIRE) -- According to a new report published by Mordor Intelligence, the telecom expense management market is experiencing strong growth as enterprises...
December 26, 2025 17:55 ET | Source: MEDIROM Healthcare Technologies Inc.

MEDIROM Partners with World

TOKYO, Dec. 26, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters:Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM, MEDIROM or the “Company”), a diversified healthcare...
December 26, 2025 07:59 ET | Source: VCI Global Limited

VCI Global Unveils 2026 “Sovereign RWA Ecosystem” Roadmap: Proprietary Exchange to Anchor Multi-Sector Asset Tokenization

KUALA LUMPUR, Malaysia, Dec. 26, 2025 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”) today announced its 2026 strategic roadmap centered on the planned launch...
December 26, 2025 07:00 ET | Source: Can-Fite BioPharma Ltd.

Can-Fite Granted Brazilian Patent for Treatment of Sexual Dysfunction

RAMAT GAN, Israel, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs...
December 24, 2025 04:25 ET | Source: Himax Technologies, Inc.

Himax Subsidiary Liqxtal and iCatch to Debut Latest Drone AI Imaging Solution at CES 2026

TAINAN, Taiwan and HSINCHU, Taiwan, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) today announced that its subsidiary Liqxtal Technology (“Liqxtal”), in collaboration...
December 23, 2025 16:46 ET | Source: Can-Fite BioPharma Ltd.

Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change

RAMAT GAN, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs...
December 23, 2025 09:06 ET | Source: Sanofi Winthrop Industrie

Communiqué de presse : Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI)

Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI) Un traitement novateur cible la BTK grâce à la modulation...
December 23, 2025 09:06 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia

Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of...
December 23, 2025 08:50 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives

- Arrangements provide increased near-term funding and extend maturity of credit agreement to early 2027 - Equity settlement mechanisms also agreed for milestone payments and contingent acquisition...
December 23, 2025 08:01 ET | Source: Vaccinex, Inc.

Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease

ROCHESTER, N.Y., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease (AD) by...